The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical and genomic alternations predictive of response to sunitinib in patients with advanced renal cell carcinoma.
 
Chung-Han Lee
Research Funding - Eisai (Inst); Pfizer (Inst)
 
Robert J. Motzer
Consulting or Advisory Role - Eisai; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Andreas Hoetker
No Relationships to Disclose
 
Oguz Akin
No Relationships to Disclose
 
Ana M. Molina
Honoraria - ASCO
Consulting or Advisory Role - AVEO; Bayer/Onyx
Research Funding - Eisai (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Eisai
 
Theresa Margaret Gold
Employment - CVS Health (I)
Leadership - CVS Health (I)
Stock and Other Ownership Interests - CVS Health (I); Merck (I)
Patents, Royalties, Other Intellectual Property - CVS Health (I)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Sujata Patil
No Relationships to Disclose
 
Manickam Janakiraman
Employment - Cancer Genetics
Stock and Other Ownership Interests - Cancer Genetics
 
Banumathy Gowrishankar
Employment - Cancer Genetics
Stock and Other Ownership Interests - Cancer Genetics
Patents, Royalties, Other Intellectual Property - Cancer Genetics
 
Jane Houldsworth
Employment - Cancer Genetics
Leadership - Cancer Genetics
Stock and Other Ownership Interests - Cancer Genetics
Research Funding - Cancer Genetics
Patents, Royalties, Other Intellectual Property - Cancer Genetics